Title | A novel mouse strain optimized for chronic human antibody administration. |
Publication Type | Journal Article |
Year of Publication | 2022 |
Authors | Gupta A, Smith P, Bournazos S, Ravetch JV |
Journal | Proc Natl Acad Sci U S A |
Volume | 119 |
Issue | 10 |
Pagination | e2123002119 |
Date Published | 2022 03 08 |
ISSN | 1091-6490 |
Abstract | Significance Species differences in IgG Fc-Fcγ receptor (FcγR) interactions have made humanized mouse models an attractive strategy to evaluate the efficacy and toxicity of human antibodies. We previously published a humanized FcγR mouse model that fully recapitulates the expression and function of these receptors in vivo. However, the immunogenicity of exogenous human IgG has made long-term assessment of antibody function challenging, since endogenous mouse anti-human IgG responses limit the duration and success of these studies. Here, we present a mouse strain that expresses human IgG1 and FcγRs, thereby conferring tolerance to chronic administration of human IgG and enabling functional assessment of antibodies. Because this strain is appropriate for chronic disease models, we expect that researchers will benefit from its use. |
DOI | 10.1073/pnas.2123002119 |
Alternate Journal | Proc Natl Acad Sci U S A |
PubMed ID | 35235456 |
PubMed Central ID | PMC8915995 |
Grant List | R01 CA244327 / CA / NCI NIH HHS / United States R35 CA196620 / CA / NCI NIH HHS / United States T32 GM007739 / GM / NIGMS NIH HHS / United States U19 AI111825 / AI / NIAID NIH HHS / United States |
Submitted by bel2021 on March 21, 2022 - 6:20pm